UCSF appoints hematology-oncology division chief
Click Here to Manage Email Alerts
Krishna Komanduri, MD, has been appointed division chief of hematology-oncology at UCSF Health.
Komanduri, recognized for his expertise in the fields of cellular immunotherapy and transplantation, also will serve as physician-in-chief of Helen Diller Family Comprehensive Cancer Center and clinical director of UCSF Living Therapeutics Initiative.
The appointments will take effect July 1.
Komanduri began his career at UCSF as a fellow in 1994 and later joined the faculty as assistant professor. He joined The University of Texas MD Anderson Cancer Center in 1999.
He has served as chief of the division of transplantation and cellular therapy at Sylvester Comprehensive Cancer Center at University of Miami since 2019. He also has served as director of the institution’s adult stem cell transplant program and associate director for clinical innovation.
His research has focused on improving the outcomes of patients undergoing transplantation with blood cancers, as well as the use of immune-based therapies for cancer.
“There is no area in medicine in which the needs are greater than hematology and oncology, and no area in which the opportunities are more thrilling,” Robert M. Wachter, MD, professor and chair of the department of medicine at UCSF, said in a press release. “I am confident that Krishna Komanduri will be an exceptional leader for our hematology-oncology enterprise, across all of our missions. ... We are pleased to welcome him back to UCSF.”
Click Here to Manage Email Alerts